| Home : January 2012 : January 05, 2012 News : MDA Awards $1 Million to Tivorsan Pharmaceuticals for Accelerating Pivotal Pre-Clinical Work on TVN-102 as a Potential Muscular Dystrophy Treatment |
MDA Awards $1 Million to Tivorsan Pharmaceuticals for Accelerating Pivotal Pre-Clinical Work on TVN-102 as a Potential Muscular Dystrophy Treatment |
January 05, 2012
TUCSON, Ariz. and PROVIDENCE, R.I., Jan. 5, 2012 /PRNewswire-USNewswire/ -- The Muscular Dystrophy Association (MDA) today announced it has awarded $1.0 million to Tivorsan Pharmaceuticals to help speed pre-clinical work vital to a filing of an Investigational New Drug (IND) application...
http://www.prnewswire.com/news-releases/mda-awards-1-million-to-tivorsan-pharmaceuticals-for-accelerating-pivotal-pre-clinical-work-on-tvn-102-as-a-potential-muscular-dystrophy-treatment-136720578.html
|
|
|
 Other Stories |
|
|
|
|
|
|
|
|
|
|
|
